Skinvisible, Inc. (SKVI) stock
SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16+0.00 (+0.06%)
Close on Oct 19, 2026Market cap $843.54KP/E –Yield –
Skinvisible cash
Cash and short-term investments held at the end of each period.
Skinvisible's cash was $3.96K at Jun 30, 2026. For fiscal 2025 it was $2.62K, down 74.7% from the year before. The highest annual figure on record is $513.42K in fiscal 2013.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.62K | -74.7% |
| FY2024 | Dec 31, 2024 | $10.34K | +1064.0% |
| FY2023 | Dec 31, 2023 | $888 | -98.9% |
| FY2022 | Dec 31, 2022 | $81.38K | +23.2% |
| FY2021 | Dec 31, 2021 | $66.04K | +84.0% |
| FY2020 | Dec 31, 2020 | $35.90K | +2665.5% |
| FY2019 | Dec 31, 2019 | $1.30K | -47.7% |
| FY2018 | Dec 31, 2018 | $2.48K | -89.4% |
| FY2017 | Dec 31, 2017 | $23.32K | +672.4% |
| FY2016 | Dec 31, 2016 | $3.02K | – |
| FY2015 | Dec 31, 2015 | $0 | -100.0% |
| FY2014 | Dec 31, 2014 | $196.60K | -61.7% |
| FY2013 | Dec 31, 2013 | $513.42K | +14.0% |
| FY2012 | Dec 31, 2012 | $450.51K | +36887.4% |
| FY2011 | Dec 31, 2011 | $1.22K | -50.9% |
| FY2010 | Dec 31, 2010 | $2.48K | -90.4% |
| FY2009 | Dec 31, 2009 | $25.87K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.96K | +3199.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.80K | -86.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.62K | -74.7% |
| Q3 FY2025 | Sep 30, 2025 | $645 | +5.4% |
| Q2 FY2025 | Jun 30, 2025 | $120 | -98.3% |
| Q1 FY2025 | Mar 31, 2025 | $13.40K | +65.4% |
| Q4 FY2024 | Dec 31, 2024 | $10.34K | +1064.0% |
| Q3 FY2024 | Sep 30, 2024 | $612 | -16.3% |
| Q2 FY2024 | Jun 30, 2024 | $6.99K | +97.0% |
| Q1 FY2024 | Mar 31, 2024 | $8.10K | -72.2% |
| Q4 FY2023 | Dec 31, 2023 | $888 | -98.9% |
| Q3 FY2023 | Sep 30, 2023 | $731 | -99.4% |
| Q2 FY2023 | Jun 30, 2023 | $3.55K | -97.8% |
| Q1 FY2023 | Mar 31, 2023 | $29.14K | -55.9% |
| Q4 FY2022 | Dec 31, 2022 | $81.38K | +65.3% |
| Q3 FY2022 | Sep 30, 2022 | $127.41K | +131.8% |
| Q2 FY2022 | Jun 30, 2022 | $160.34K | +1165.8% |
| Q4 FY2021 | Dec 31, 2021 | $66.04K | +84.0% |
| Q3 FY2021 | Sep 30, 2021 | $49.22K | +316.5% |
| Q2 FY2021 | Jun 30, 2021 | $54.98K | +56.7% |
| Q1 FY2021 | Mar 31, 2021 | $12.67K | +92.5% |
| Q4 FY2020 | Dec 31, 2020 | $35.90K | +2665.5% |
| Q3 FY2020 | Sep 30, 2020 | $11.82K | +9.1% |
| Q2 FY2020 | Jun 30, 2020 | $35.09K | – |
| Q1 FY2020 | Mar 31, 2020 | $6.58K | +228.1% |
| Q4 FY2019 | Dec 31, 2019 | $1.30K | -47.7% |
| Q3 FY2019 | Sep 30, 2019 | $10.83K | +30.7% |
| Q2 FY2019 | Jun 30, 2019 | $0 | -100.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.01K | -93.9% |
| Q4 FY2018 | Dec 31, 2018 | $2.48K | -89.4% |
| Q3 FY2018 | Sep 30, 2018 | $8.29K | -90.9% |
| Q2 FY2018 | Jun 30, 2018 | $2.52K | -52.0% |
| Q1 FY2018 | Mar 31, 2018 | $32.96K | +814.2% |
| Q4 FY2017 | Dec 31, 2017 | $23.32K | +672.4% |
| Q3 FY2017 | Sep 30, 2017 | $91.14K | – |
| Q2 FY2017 | Jun 30, 2017 | $5.25K | – |
| Q1 FY2017 | Mar 31, 2017 | $3.61K | – |
| Q4 FY2016 | Dec 31, 2016 | $3.02K | – |
See a number that looks wrong?